88 related articles for article (PubMed ID: 27910060)
1. MicroRNA Delivery Strategies to the Lung in a Model of Pulmonary Hypertension.
Deng L; Baker AH; Bradshaw AC
Methods Mol Biol; 2017; 1521():325-338. PubMed ID: 27910060
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension.
Pullamsetti SS; Doebele C; Fischer A; Savai R; Kojonazarov B; Dahal BK; Ghofrani HA; Weissmann N; Grimminger F; Bonauer A; Seeger W; Zeiher AM; Dimmeler S; Schermuly RT
Am J Respir Crit Care Med; 2012 Feb; 185(4):409-19. PubMed ID: 22161164
[TBL] [Abstract][Full Text] [Related]
3. Leptin signalling system as a target for pulmonary arterial hypertension therapy.
Huertas A; Tu L; Thuillet R; Le Hiress M; Phan C; Ricard N; Nadaud S; Fadel E; Humbert M; Guignabert C
Eur Respir J; 2015 Apr; 45(4):1066-80. PubMed ID: 25745038
[TBL] [Abstract][Full Text] [Related]
4. The hypoxia-induced microRNA-130a controls pulmonary smooth muscle cell proliferation by directly targeting CDKN1A.
Brock M; Haider TJ; Vogel J; Gassmann M; Speich R; Trenkmann M; Ulrich S; Kohler M; Huber LC
Int J Biochem Cell Biol; 2015 Apr; 61():129-37. PubMed ID: 25681685
[TBL] [Abstract][Full Text] [Related]
5. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
[TBL] [Abstract][Full Text] [Related]
6. AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension.
Brock M; Samillan VJ; Trenkmann M; Schwarzwald C; Ulrich S; Gay RE; Gassmann M; Ostergaard L; Gay S; Speich R; Huber LC
Eur Heart J; 2014 Dec; 35(45):3203-11. PubMed ID: 22450430
[TBL] [Abstract][Full Text] [Related]
7. Classical transient receptor potential channel 1 in hypoxia-induced pulmonary hypertension.
Malczyk M; Veith C; Fuchs B; Hofmann K; Storch U; Schermuly RT; Witzenrath M; Ahlbrecht K; Fecher-Trost C; Flockerzi V; Ghofrani HA; Grimminger F; Seeger W; Gudermann T; Dietrich A; Weissmann N
Am J Respir Crit Care Med; 2013 Dec; 188(12):1451-9. PubMed ID: 24251695
[TBL] [Abstract][Full Text] [Related]
8. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of miR-495 Improves Both Vascular Remodeling and Angiogenesis in Pulmonary Hypertension.
Fu J; Bai P; Chen Y; Yu T; Li F
J Vasc Res; 2019; 56(2):97-106. PubMed ID: 31030195
[TBL] [Abstract][Full Text] [Related]
10. Long Range Endocrine Delivery of Circulating miR-210 to Endothelium Promotes Pulmonary Hypertension.
Zhao J; Florentin J; Tai YY; Torrino S; Ohayon L; Brzoska T; Tang Y; Yang J; Negi V; Woodcock CC; Risbano MG; Nouraie SM; Sundd P; Bertero T; Dutta P; Chan SY
Circ Res; 2020 Aug; 127(5):677-692. PubMed ID: 32493166
[TBL] [Abstract][Full Text] [Related]
11. PAR-2 inhibition reverses experimental pulmonary hypertension.
Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling.
Kang BY; Park KK; Kleinhenz JM; Murphy TC; Green DE; Bijli KM; Yeligar SM; Carthan KA; Searles CD; Sutliff RL; Hart CM
Am J Respir Cell Mol Biol; 2016 Jan; 54(1):136-46. PubMed ID: 26098770
[TBL] [Abstract][Full Text] [Related]
13. Smooth Muscle Insulin-Like Growth Factor-1 Mediates Hypoxia-Induced Pulmonary Hypertension in Neonatal Mice.
Sun M; Ramchandran R; Chen J; Yang Q; Raj JU
Am J Respir Cell Mol Biol; 2016 Dec; 55(6):779-791. PubMed ID: 27438786
[TBL] [Abstract][Full Text] [Related]
14. Salidroside attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2a receptor related mitochondria-dependent apoptosis pathway.
Huang X; Zou L; Yu X; Chen M; Guo R; Cai H; Yao D; Xu X; Chen Y; Ding C; Cai X; Wang L
J Mol Cell Cardiol; 2015 May; 82():153-66. PubMed ID: 25772255
[TBL] [Abstract][Full Text] [Related]
15. Discordant Regulation of microRNA Between Multiple Experimental Models and Human Pulmonary Hypertension.
Schlosser K; Taha M; Deng Y; Jiang B; Stewart DJ
Chest; 2015 Aug; 148(2):481-490. PubMed ID: 25763574
[TBL] [Abstract][Full Text] [Related]
16. Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension.
McLendon JM; Joshi SR; Sparks J; Matar M; Fewell JG; Abe K; Oka M; McMurtry IF; Gerthoffer WT
J Control Release; 2015 Jul; 210():67-75. PubMed ID: 25979327
[TBL] [Abstract][Full Text] [Related]
17. Analysis of hypoxia-induced noncoding RNAs reveals metastasis-associated lung adenocarcinoma transcript 1 as an important regulator of vascular smooth muscle cell proliferation.
Brock M; Schuoler C; Leuenberger C; Bühlmann C; Haider TJ; Vogel J; Ulrich S; Gassmann M; Kohler M; Huber LC
Exp Biol Med (Maywood); 2017 Mar; 242(5):487-496. PubMed ID: 28056547
[TBL] [Abstract][Full Text] [Related]
18. MiR-140-5p regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and differentiation by targeting Dnmt1 and promoting SOD2 expression.
Zhang Y; Xu J
Biochem Biophys Res Commun; 2016 Apr; 473(1):342-348. PubMed ID: 27021683
[TBL] [Abstract][Full Text] [Related]
19. Lung overexpression of angiostatin aggravates pulmonary hypertension in chronically hypoxic mice.
Pascaud MA; Griscelli F; Raoul W; Marcos E; Opolon P; Raffestin B; Perricaudet M; Adnot S; Eddahibi S
Am J Respir Cell Mol Biol; 2003 Oct; 29(4):449-57. PubMed ID: 12714372
[TBL] [Abstract][Full Text] [Related]
20. YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice.
Huh JW; Kim SY; Lee JH; Lee YS
Pulm Pharmacol Ther; 2011 Dec; 24(6):638-46. PubMed ID: 21963997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
